Proactive Compliance and Purity

A: The most critical step is the IFRA Compliance Check. We run the ingredient, and its proposed concentration, through the latest IFRA Standards to ensure it is safe for the intended product category (e.g., skin contact, air diffusion). If the ingredient fails the IFRA restriction for that category, it is immediately rejected or reformulated.

A: We use Gas Chromatography–Mass Spectrometry (GC-MS) analysis. This lab test creates a unique “chemical fingerprint” of the essential oil. We compare this fingerprint against established reference standards. If the GC-MS analysis reveals unexpected chemical components (adulterants) or deviations from the natural profile, the batch is rejected, ensuring only high-purity oils are used.

A: We manage allergens in two ways:

1. Restriction: We consciously minimize the use of common high-risk allergens whenever possible without compromising the scent profile.

2. Transparency: For all EU-bound products, we provide a detailed Allergen Declaration, quantifying the presence of the 26 substances that must be listed on the product label if they exceed specified thresholds. This supports your brand’s mandatory labeling requirements.

A: We practice proactive risk mitigation:

1. Immediate Notification: We immediately notify the client that their formula requires adjustment due to a regulatory change.

2. Compliant Reformulation: Our R&D team rapidly provides a compliant replacement formula that uses the new, permitted ingredients while maintaining the original scent profile as closely as possible, ensuring zero lapse in market legality.

A: Yes. We actively screen all incoming materials against the continually updated Prop 65 list. If an ingredient is on the list, we advise the client on the need for the required clear and reasonable warning label for products destined for sale in California, ensuring full legal compliance in that key US market.

A: We provide the necessary regulatory data and compliance documentation for the final product (SDS, full INCI ingredient list, Allergen Statement, and concentration data) which is sufficient for regulatory filings (like CPNP in the EU). However, the highly proprietary, exact breakdown of the flavor components used in the fragrance oil remains our Intellectual Property (IP), unless otherwise negotiated in an OEM contract.